Save Search

1 to 7

Sort By:

Date Target Transaction Type
Value: $mlns
Acquirer Seller
2025-12-15 Cofactor Genomics
Life Science
St. Louis, Missouri
www.cofactorgenomics.com

Cofactor Genomics is a biotechnology company that develops a platform based on RNA that enables early detection and diagnosis of a disease. Cofactor Genomics is based in St. Louis, Missouri.

Stake Purchase

LabCorp
Company
Test/Measurement Equipment
Burlington, North Carolina
www.labcorp.com

-
Deal Article Deal Link  
2025-03-10 Chemfield Cellulose
Life Science
Nagpur, India
www.chemfields.com

Chemfield Cellulose is a developer and manufacturer of MCC (microcrystalline cellulose) excipients and its derivatives. Microcrystalline cellulose is a refined, high-purity cellulose powder that serves as a critical excipient in pharmaceutical formulations. It is also widely used in dietary supplements and food applications. Chemfield Cellulose was founded in 1992 and is based in Nagpur, Maharashtra.

Advisor: BDA Partners
Stake Purchase

Oji Holdings
Company
Forest Products
Tokyo, Japan
www.ojiholdings.co.jp

-
Deal Article Deal Link  
2025-07-02 Principle Diagnostics
Life Science
Bethlehem, Pennsylvania
www.principlediagnostics.com

Principle Diagnostics provides toxicology, molecular, and genetic testing services to a broad base of consumers, patients, providers, and other laboratories. Principle Diagnostics was founded in 2015 and is based in Bethlehem, Pennsylvania.

Advisors: Gordon Feinblatt , Berkery, Noyes & Co.
Stake Purchase

Aqueous Health Holdings
Company
Life Science
Phoenix, Arizona
www.aqueous-health.com

Advisor: Polsinelli

-
Deal Article Deal Link  
2025-05-13 Granata Bio
Life Science
Duxbury, Massachusetts
www.granata.bio

Granata Bio is a U.S.-based biopharmaceutical company dedicated to advancing innovation in women's health and infertility. Granata Bio's pipeline includes a range of fertility therapies, with collaborations spanning multiple drug classes to address unmet needs in reproductive medicine. Granata Bio was formed in 2018 and is based in Duxbury, Massachusetts.

Stake Purchase

Gedeon Richter
Company
Life Science
Budapest, Hungary
www.gedeonrichter.com

-
Deal Article Deal Link  
2025-09-04 MRM Health
Life Science
Gent, Belgium
mrmhealth.com

MRM Health is a clinical-stage biotech developing innovative microbiome-based therapeutics for inflammatory diseases and immune-oncology. MRM Health is based in Gent, Belgium.

Stake Purchase

Biocodex USA
Company
Life Science
Redwood City, California
www.biocodex.us

-
Deal Article Deal Link  
2025-06-09 Felix
Life Science
Dublin, Ireland
www.felixvet.com

Felix is a global Gx animal pharma company that develops, manufactures and supplies to distributors and other branded Gx players for private labelling, particularly in the US. Felix is based in Dublin, Ireland.

Advisor: Lincoln International
Stake Purchase

Advent International
Investor
Private Equity Firm
Boston, Massachusetts
www.adventinternational.com

Advisor: Guggenheim Securities

-
Deal Article Deal Link  
2025-12-11 MyOme
Life Science
Palo Alto, California
www.myome.com

MyOme is a clinical whole-genome analysis platform company that provides genomic sequencing and analysis services to help individuals and healthcare providers understand genetic risk factors for inherited diseases, guide personalised health decisions, and support diagnostic evaluation. MyOme was founded in 2017 and is headquartered in Menlo Park, California.

Stake Purchase

Illumina
Company
Life Science
San Diego, California
www.illumina.com

-
Deal Article Deal Link  
Avg $0.0
0.0x EBITDA
0.0x REVENUE

Try Mergr Free — Access the Full List Today

Stop Manually Tracking Deals.
Get Full Access. Cancel Anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.

Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.

The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.